AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $1.46M invested in AIM ImmunoTech in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$498K
2
+$327K
3
+$222K
4
Jane Street
Jane Street
New York
+$72K
5
Morgan Stanley
Morgan Stanley
New York
+$45.7K

Top Sellers

1
-$288K
2
-$9K
3
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$498K
2
$327K
3
$222K
4
$72K
5
$61K
6
$50K
7
$46K
8
$38K
9
$32K
10
$30K
11
$27K
12
$25K
13
$22K
14
$5K
15
$3K
16
$1K
17
$1K
18
$584
19
–
20
–
21
–